» Articles » PMID: 36331348

Preclinical Ocular Changes in Systemic Lupus Erythematosus Patients by Optical Coherence Tomography

Abstract

Objective: The aim of the present study was to detect preclinical changes in SLE patients in retinal microvascularization or retinal and optical nerve structure by optical coherence tomography.

Methods: This cross-sectional, single-centre study aimed to describe structural changes [macular and retinal nerve fibre layer (RNFL) thickness] by structural spectral-domain optical coherence tomography (SD-OCT) and perifoveal vascular [vessel density (VD) and vascular perfusion (VP) and foveal avascular zone (FAZ) structural parameters] findings by OCT angiography (OCTA) in 78 SLE patients and 80 healthy volunteers. In addition, we analysed their association with clinical and laboratory parameters, medications received, disease duration, and SLE activity and damage.

Results: Structural parameters by SD-OCT and perifoveal vascular parameters by OCTA were decreased in SLE patients compared with controls. OCTA parameters (VD, VP and FAZ circularity) and macular thickness were also decreased in patients with longer disease duration (>10 years). The presence of aPLs was associated with a decreased RNFL thickness, mainly in the inferior quadrants. Patients developing APS also showed decreased RNFL thickness and OCTA flow changes. SD-OCT and OCTA results were not associated with disease activity. Foveal structural parameters were lower in patients with higher damage score.

Conclusion: SD-OCT and OCTA can detect preclinical structural and microcirculatory changes in SLE patients. Structural and perifoveal vascular macular changes in SLE patients are related to disease duration. Macular structural parameters were impaired in patients with higher disease damage. APS seems to be associated with preclinical damage to the optic nerve and impairment of the perifoveal microvasculature.

Citing Articles

Increased retinal thickness in sarcoidosis patients with ocular system involvement visualized with optical coherence tomography: a cross-sectional study.

Byg K, Ellingsen T, Wied J, Peiris M, Lowater S, Sejbaek T Rheumatol Int. 2025; 45(3):66.

PMID: 40014150 PMC: 11868241. DOI: 10.1007/s00296-025-05818-2.


Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus.

Meng L, Wang Y, Yang Z, Lin S, Wang Y, Chen H Front Immunol. 2024; 15:1395609.

PMID: 39091490 PMC: 11291259. DOI: 10.3389/fimmu.2024.1395609.


Retinal sublayer analysis in juvenile systemic lupus erythematosus without lupus retinopathy.

Xu S, Zhang Y Clin Rheumatol. 2024; 43(9):2825-2831.

PMID: 38982013 DOI: 10.1007/s10067-024-07064-6.


Factors associated with early hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus.

Araujo O, Hernandez-Negrin H, Casaroli-Marano R, Hernandez-Rodriguez J, Adan A, Espinosa G Graefes Arch Clin Exp Ophthalmol. 2024; 262(9):2823-2832.

PMID: 38578332 DOI: 10.1007/s00417-024-06461-6.


New proposal for a multimodal imaging approach for the subclinical detection of hydroxychloroquine-induced retinal toxicity in patients with systemic lupus erythematosus.

Araujo O, Casaroli-Marano R, Hernandez-Rodriguez J, Figueras-Roca M, Budi V, Morato M BMJ Open Ophthalmol. 2024; 9(1).

PMID: 38499344 PMC: 10953034. DOI: 10.1136/bmjophth-2023-001608.